9QI9 image
Deposition Date 2025-03-17
Release Date 2026-01-28
Last Version Date 2026-01-28
Entry Detail
PDB ID:
9QI9
Keywords:
Title:
Crystal structure of styrene monooxygenase RhStyA
Biological Source:
Source Organism(s):
Rhodococcus (Taxon ID: 1827)
Expression System(s):
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.19
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Styrene monooxygenase
Gene (Uniprot):styA
Chain IDs:A
Chain Length:446
Number of Molecules:1
Biological Source:Rhodococcus
Primary Citation

Abstact

The enantioselective manipulation of abundant flat (hetero)aromatic building blocks through either dearomatization, to establish new stereocenters, or cross-coupling, to construct a stereogenic axis, is an attractive means to generate three-dimensional molecular architectures. By merging the selectivity of engineered biocatalysts with the versatility of chemical synthesis, we establish a new platform for the metal-free enantioselective manipulation of sulfur-containing heteroaromatics, allowing either point or axial chirality to be set. The key to this approach is our ability to leverage the prochirality of sulfur heteroarenes; biocatalytic oxidation of benzothiophenes "switches on" reactivity and establishes a sulfur stereocenter that directs the stereochemical course of subsequent cross-couplings with non-prefunctionalized partners. Exploiting a previously unexplored mechanism, either point-to-point or point-to-axial chirality transfer from sulfur selectively delivers two different sets of chiral molecules. Enzyme evolution is used to convert a wild-type oxygenase into an efficient and selective engineered S-oxygenase capable of furnishing enantiopure benzothiophene S-oxides─little-known sulfoxides whose configurational stability we map out. Our integrated chemoenzymatic approach provides a blueprint for unlocking the potential of sulfur chirality, lying dormant in important heterocycles, to direct transformations that deliver diverse enantioenriched products.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback